Header Logo

Connection

KIMBERLY WALKER to Clinical Trials, Phase I as Topic

Back to Details
This is a "connection" page, showing publications KIMBERLY WALKER has written about Clinical Trials, Phase I as Topic.
KIMBERLY WALKER
Connection Strength
0.056
Clinical Trials, Phase I as Topic
  1. Macrophage Therapy for Acute Liver Injury (MAIL): a study protocol for a phase 1 randomised, open-label, dose-escalation study to evaluate safety, tolerability and activity of allogeneic alternatively activated macrophages in patients with paracetamol-induced acute liver injury in the UK. BMJ Open. 2024 Dec 09; 14(12):e089417.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.